Skip to content

F-STAR THERAPEUTICS, INC.

CIK 0001566373

← back to feed
Revenue (TTM)
$1.88M
+88.1% YoY Q3 Sep 2022
Net Income (TTM)
−$60.28M
−22.1% YoY Q3 Sep 2022
EPS Diluted (TTM)
−$3.15
+22.3% YoY Q3 Sep 2022
Gross Margin
—
Q3 Sep 2022
Operating Margin
-2,701.3%
Q3 Sep 2022
Net Margin
-3,213.2%
Q3 Sep 2022
Free Cash Flow (TTM)
−$34.89M
Q3 Sep 2022
Cash
$35.57M
Q3 Sep 2022
Total Debt
$9.84M
Q3 Sep 2022
Shares Outstanding
21.98M sh
Q3 Sep 2022

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings